Definitive Contract 75F40119C10150
Award Date 9/27/19
Potential Completion Date 12/31/25
Potential Value $1.9M
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Food and Drug Administration (FDA) to the Health and Environmental Sciences Institute (HESI), a non-profit organization. The contract, worth $267,658.00, is for a project titled "VALIDATING HUMAN STEM CELL CARDIOMYOCYTE TECHNOLOGY FOR BETTER PREDICTIVE ASSESSMENT OF DRUG-INDUCED CARDIAC TOXICITY." The contract is a definitive contract with a firm fixed price. This contract appears to be supporting the FDA's efforts to evaluate the reliability...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to TSE Systems, Inc., a for-profit manufacturer of advanced biomedical research equipment and scientific instrumentation. The $139,585.14 contract is for the delivery of an additional sampling system to fit on existing inhalation exposure units, along with a post-warranty service agreement option. The award does not have a...
- This is a $1,904,355.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA), a civilian government agency, to the Institute Of Quantitative Systems Pharmacology, a non-profit organization. The contract is for basic and applied research with two key objectives: (1) to test the hypothesis that variabilities in nanoparticle (NP) properties and tumor targets cause uncertainties in "FORMULA", and (2) to develop computational models to predict the...
- <p>The Department of Health and Human Services Food and Drug Administration awarded a $175,000.00 firm fixed price purchase order to Cytobioscience, Inc., a for-profit organization, to upgrade the agency's in-house automated patch clamp system. The contract was awarded on September 2, 2018, with a completion date of November 30, 2018. The contract was not set aside for any specific socioeconomic category.</p>
- Hesperos, LLC was awarded a firm fixed price purchase order not to exceed $32,235 by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations. The contract has a period of performance through February 26, 2025 to provide goods or services in support of the agency's programs. As the prime contractor, Hesperos will likely utilize its organ-on-a-chip technology and related expertise to conduct in vitro testing, disease modeling, or...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $111,539.32 firm-fixed-price purchase order to EHT Technologies GMBH, a for-profit limited liability company manufacturer, for a Test System of Engineered Heart Tissues (EHT). This system will be used by the FDA's Division of Applied Regulatory Science to study variations in heart cell contractility resulting from exposure to certain drugs or drug combinations in a more mature setting. The contract...
- This is a $105,606.62 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) to the Foundation for Advanced Education in the Sciences, Inc. (FAES), a non-profit organization based in Bethesda, Maryland. The contract is for the provision of services, with no set-aside designation. FAES has a history of managing fellowship programs and providing administrative support for research training initiatives across multiple NIH institutes and centers. This award is...
- This is a $597,340.00 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA) to QPS LLC, a minority-owned limited liability company, for a scientific study related to the assessment of in vitro percutaneous absorption, in vitro rate of release, and physicochemical properties. The contract does not have a set-aside designation, indicating it was an open market procurement. QPS LLC is an experienced federal contractor, having been awarded multiple contracts and task orders...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), part of the Department of Health and Human Services (HHS), to TSE Systems, Inc., a for-profit manufacturer of advanced biomedical research equipment. The $79,902.56 contract is for the delivery of specialized physiological monitoring and research systems, including Stellar implantable transmitters, a receiver, and associated upgrades. This sole-source contract was...
- The Department of Health and Human Services Food and Drug Administration awarded a $727,122.40 firm fixed price purchase order to 3T Federal Solutions LLC of Austin, Texas. The contract calls for delivery of an automated high throughput patch clamp system to support the FDA's efforts to characterize drug effects on heart ion channels. The system must meet technical performance requirements to electrophysiologically assess individual cells at high volume, as requested in the small business...